156 related articles for article (PubMed ID: 19091080)
1. Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock.
Link A; Selejan S; Maack C; Lenz M; Böhm M
Crit Care; 2008; 12(6):R159. PubMed ID: 19091080
[TBL] [Abstract][Full Text] [Related]
2. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Seldon PM; Barnes PJ; Meja K; Giembycz MA
Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
[TBL] [Abstract][Full Text] [Related]
3. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
[TBL] [Abstract][Full Text] [Related]
4. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
[TBL] [Abstract][Full Text] [Related]
5. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
Mirlashari MR; Lyberg T
Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
7. Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice.
Fischer W; Schudt C; Wendel A
Biochem Pharmacol; 1993 Jun; 45(12):2399-404. PubMed ID: 8392340
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and exercise: Inhibition of monocytic intracellular TNF production by acute exercise via β
Dimitrov S; Hulteng E; Hong S
Brain Behav Immun; 2017 Mar; 61():60-68. PubMed ID: 28011264
[TBL] [Abstract][Full Text] [Related]
9. Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells.
Nevzorova J; Evans BA; Bengtsson T; Summers RJ
Br J Pharmacol; 2006 Feb; 147(4):446-54. PubMed ID: 16415914
[TBL] [Abstract][Full Text] [Related]
10. beta2-adrenergic receptor stimulation-induced immunosuppressive effects possibly through down-regulation of co-stimulatory molecules, ICAM-1, CD40 and CD14 on monocytes.
Kuroki K; Takahashi HK; Iwagaki H; Murakami T; Kuinose M; Hamanaka S; Minami K; Nishibori M; Tanaka N; Tanemoto K
J Int Med Res; 2004; 32(5):465-83. PubMed ID: 15458278
[TBL] [Abstract][Full Text] [Related]
11. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents.
Siegmund B; Eigler A; Moeller J; Greten TF; Hartmann G; Endres S
Eur J Pharmacol; 1997 Feb; 321(2):231-9. PubMed ID: 9063693
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.
Han SH; Kim JH; Martin M; Michalek SM; Nahm MH
Infect Immun; 2003 Oct; 71(10):5541-8. PubMed ID: 14500472
[TBL] [Abstract][Full Text] [Related]
14. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis.
Astiz M; Saha D; Lustbader D; Lin R; Rackow E
J Lab Clin Med; 1996 Dec; 128(6):594-600. PubMed ID: 8960643
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
[TBL] [Abstract][Full Text] [Related]
16. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells.
Semmler J; Wachtel H; Endres S
Int J Immunopharmacol; 1993 Apr; 15(3):409-13. PubMed ID: 8505151
[TBL] [Abstract][Full Text] [Related]
17. CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia.
de Werra I; Zanetti G; Jaccard C; Chioléro R; Schaller MD; Yersin B; Glauser MP; Calandra T; Heumann D
Swiss Med Wkly; 2001 Jan; 131(3-4):35-40. PubMed ID: 11219189
[TBL] [Abstract][Full Text] [Related]
18. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
19. The PDE4 inhibitor rolipram prevents NF-kappaB binding activity and proinflammatory cytokine release in human chorionic cells.
Hervé R; Schmitz T; Evain-Brion D; Cabrol D; Leroy MJ; Méhats C
J Immunol; 2008 Aug; 181(3):2196-202. PubMed ID: 18641359
[TBL] [Abstract][Full Text] [Related]
20. Combined anti-inflammatory effects of β2-adrenergic agonists and PDE4 inhibitors on astrocytes by upregulation of intracellular cAMP.
Christiansen SH; Selige J; Dunkern T; Rassov A; Leist M
Neurochem Int; 2011 Nov; 59(6):837-46. PubMed ID: 21871511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
